Follistatin, endoglin predict postallogeneic HCT NRMFebruary 27, 2017Cellular TherapyPatient & Survivor Care
Early mortality risk factors in adult sickle cell disease support ECG screeningFebruary 26, 2017Anemia
Immune recovery may predict survival in myeloma patients with stem cell transplantsFebruary 25, 2017Multiple Myeloma
Older AML patients benefit from frailty assessment and interventionsFebruary 25, 2017AMLPatient & Survivor Care
Phase III trial: VZV protects auto-HCT patientsFebruary 25, 2017Multiple MyelomaT Cell LymphomasMantle Cell LymphomaIndolent LymphomaAggressive Lymphomas
Fewer post-transplant CMV infections with novel antiviral prophylaxisFebruary 24, 2017Transfusion MedicinePatient & Survivor Care
Multiple myeloma: Lenalidomide approved as maintenance therapy after auto-HSCTFebruary 22, 2017Multiple Myeloma
